舒血宁注射液治疗肺心病高粘血症的临床疗效分析  

Analysis on the Clinical Efficacy of Shuxuening Injection in the Treatment of Pulmonary Heart Disease Complicated with Hyperviscosity

作　　者：廖晓东 

机构地区：[1]韶关市铁路医院门诊部,广东韶关512023

出　　处：《临床医学工程》2016年第10期1347-1348,共2页Clinical Medicine & Engineering

摘　　要：目的探讨舒血宁注射液治疗肺心病高粘血症的临床效果。方法选取2014年2月至2016年2月于我院进行诊治的肺心病高粘血症患者90例,分为观察组和对照组各45例,对照组给予常规治疗,观察组在常规治疗基础上给予舒血宁注射液治疗,比较两组患者的临床疗效。结果观察组患者的临床总有效率(95.56%)明显高于对照组(77.78%),差异有统计学意义(P<0.05)。治疗后,两组患者的血浆粘度、红细胞压积、纤维蛋白原、全血粘度低切、全血粘度高切、血沉等均较治疗前显著下降(P<0.05),且观察组下降较对照组明显(P<0.05)。结论舒血宁注射液治疗有助于提高肺心病高粘血症的临床疗效。Objective To explore the curative effect of Shuxuening injection for the treatment of patients with pulmonary heart disease complicated with hyperviscosity. Methods A total of 90 cases of patients with pulmonary heart disease complicated with hyperviscosity admitted to our hospital fi＇om February 2014 to February 2016 were selected and randomly divided into two groups, with 45 cases in each group. The control group was given routine therapy, while the observation group was given Shuxuening injection on the basis of routine therapy. The clinical effects of two groups were compared. Results The total effective rate of observation group was 95.56%, significantly higher than 77.78% of control group （P 〈0.05）. After therapy, the levels of plasma viscosity, hematocrit, fibrinogen, low shear of blood viscosity, high shear of blood viscosity and ESR of both groups decreased significantly （P 〈0.05）, and the reduction of observation group was more significant than that of control group （P〈0.05）. Conclusions Shuxuening injection can help to improve the clinical efficacy of patients with pulmonary heart disease complicated with hyperlipemia.

关 键 词：肺心病 高粘血症 舒血宁注射液 临床疗效 

分 类 号：R541.5[医药卫生—心血管疾病]